Inhibition of dUTPase represents a novel therapeutic strategy in triple negative breast cancer.

Robert Ladner, Craig Davison, Catherine Knowlson, Kienan Savage, Karl Mulligan, Peter Wilson, Patrick Johnston

Research output: Contribution to conferencePosterpeer-review

Original languageEnglish
Publication statusPublished - 2018
Event30th EORTC-NCI-AACR Molecular Targets in Cancer Therapeutics - Dublin , Ireland
Duration: 13 Nov 2018 → …

Conference

Conference30th EORTC-NCI-AACR Molecular Targets in Cancer Therapeutics
CountryIreland
CityDublin
Period13/11/2018 → …

Cite this